Advertisement
Screener

Standard BioTools Inc. (LAB) Material Contracts, 2016

Standard BioTools Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2016-11-09: Form 10-Q; Exhibit 10.2; Description Employment and Severance Agreement, effective as of August 1, 2016, by and between the Company and Stephen Christopher Linthwaite.
  • 2016-11-09: Form 10-Q; Exhibit 10.1; Description Offer Letter to Stephen Christopher Linthwaite, dated July 14, 2016.
  • 2016-05-23: Form 8-K; Exhibit 10.1; Description Offer Letter to Jennifer Lee dated March 30, 2016..
FiledFormExhibitDescription
2016-11-0910-Q10.2Employment and Severance Agreement, effective as of August 1, 2016, by and between the Company and Stephen Christopher Linthwaite
2016-11-0910-Q10.1Offer Letter to Stephen Christopher Linthwaite, dated July 14, 2016
2016-05-238-K10.1Offer Letter to Jennifer Lee dated March 30, 2016.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01